Glaukos Corporation Profile Avatar - Palmy Investing

Glaukos Corporation

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro…

Medical - Devices
US, San Clemente [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of GKOS's Analysis
CIK: 1192448 CUSIP: 377322102 ISIN: US3773221029 LEI: - UEI: -
Secondary Listings
GKOS has no secondary listings inside our databases.